3/17/2025NMPA Solicits Comments on Draft Revision of GMP Annex for Sterile Drug...

3/17/2025Innovent Launches GLORY-3: A Phase 3 Head-to-Head Study of Mazdutide v...

3/14/2025BioCity Announces Clinical Collaboration to Evaluate BC3195 in Combo w...

3/14/2025Fosun Pharma to Divest United Family Healthcare for $124.1M

3/14/2025Zai Lab/Pfizer's BLA for Tivdak Accepted in China

3/14/2025Innovent's IBI311 Becomes First Chinese-Made IGF-1R Antibody Approved ...

3/14/2025Recent Executive Moves

3/14/2025PharmCube's Overview and Insights into China's Pharmaceutical Market 2...

3/13/2025China Issues Guidelines for Informatization of County-Level Healthcare...

3/12/2025Akeso Initiates Phase III Trial of Ivonescimab Plus Chemotherapy for m...

3/12/2025Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generati...

3/12/2025Novartis' Cosentyx Receives Fifth Indication Approval in China for Hid...

3/11/2025TYK Medicines Announces Pivotal Phase II Trial of TY-9591 Vs Osimertin...

3/11/2025Pfizer's Elrexfio Receives Conditional Approval in China for Advanced ...

3/11/2025MindRank's AI-Designed Dual Kinase Inhibitor MRANK-106 Receives FDA IN...

3/11/2025Over 100 Chinese Pharma Firms Report Losses as 319 Firms Release 2024 ...

3/10/2025China to Expand Mental Health Services Nationwide: Official

3/10/2025China Expands BMI Coverage to Over 90% of Village Clinics

3/10/2025China Approves AbbVie's Skyrizi for Active Crohn's Disease Treatment

3/10/2025The Bright Future Amidst Challenges: An Outlook on China's Pharma Econ...

3/10/2025China Biopharma Tracker – February 2025 (PharmaDJ)

3/7/2025Enhua Pharma Acquires 10.4% Stake in NeuroThree with $3.5M Investment...

3/7/2025Innovent Launches Phase 2 Trial of IBI362 for Heart Failure Patients w...

3/7/2025Recent Executive Moves

3/6/2025Nhwa Pharma Acquires Stake in Neuro3 to Expand CNS Drug Pipeline  

3/6/2025AI, Biomanufacturing, and Six Takeaways from China’s Government Work ...

3/5/2025China to Adjust Centralized Drug Procurement Policies

3/4/2025Amoytop's Strategic Acquisition of Skyline Assets Marks Expansion into...

3/4/2025BeiGene's TEVIMBRA Approved in U.S. for First-line Treatment of Advanc...

3/4/2025Trump's 'America First' Investment Policy Raises Uncertainty for US-Ch...

Page:4/354 Total number of articles:10618: [First][<<] [2] [3] [4] [5] [6] [>>] [End]